Cargando…

Is It Time to Commit to a Process to Re-Evaluate Oncology Drugs? A Descriptive Analysis of Systemic Therapies for Solid Tumour Indications Reviewed in Canada from 2017 to 2021

We undertook an analysis of the Canadian Agency for Drugs and Technologies in Health (CADTH)’s health technology assessments (HTAs) of systemic therapies for solid tumour indications to determine if a mechanism to re-evaluate HTA decisions is needed based on the level of certainty supporting the ori...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sehdev, Sandeep, Chambers, Alexandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947363/ https://www.ncbi.nlm.nih.gov/pubmed/35323356 http://dx.doi.org/10.3390/curroncol29030156

Ejemplares similares

Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain
por: Rayson, Daniel, et al.
Publicado: (2022)

Liquid Biopsies: Emerging role and clinical applications in solid tumours
por: Sisodiya, Sandeep, et al.
Publicado: (2023)

Clinical Trial Diversity in Oncology: FDA Takes Action with Post–Marketing Requirements or Commitments
por: Kim, Janice, et al.
Publicado: (2022)

Lessons and Recommendations from a Pentobarbital Shortage: US and Canada 2021
por: Cooney, Kathleen, et al.
Publicado: (2022)

The role and economics of immunotherapy in solid tumour management
por: Worku, Dominic Adam, et al.
Publicado: (2020)

Re-discovering NK cell allo-reactivity in the therapy of solid tumors
por: Castagna, Luca, et al.
Publicado: (2016)

American Society of Clinical Oncology 2021 Podcast: HR+, HER2− Breast Cancer
por: Cheung, Kwok-Leung
Publicado: (2021)

Re-programming tumour cell metabolism to treat cancer: no lone target for lonidamine
por: Bhutia, Yangzom D., et al.
Publicado: (2016)

The re‐emergence of diphtheria in Nigeria: Descriptive assessment of the post‐COVID‐19 crisis management
por: Ogunniyi, Tolulope J., et al.
Publicado: (2023)

Initial indicators of the public health impacts of non-medical cannabis legalization in Canada
por: Fischer, Benedikt, et al.
Publicado: (2020)

Teaching an old dog new tricks: re-engineering IL-2 for immuno-oncology applications
por: Sznol, Mario, et al.
Publicado: (2023)

The relationship between voluntary product (re) formulation commitments and changes in the nutritional quality of products offered by the top packaged food and beverage companies in Canada from 2013 to 2017
por: Vergeer, Laura, et al.
Publicado: (2022)

Re-imagining Research: A Bold Call, but Bold Enough? Comment on "Experience of Health Leadership in Partnering with University-Based Researchers in Canada: A Call to ‘Re-Imagine’ Research"
por: Holmes, Bev J.
Publicado: (2019)

Commitment devices in the treatment of diabetic foot ulcers
por: Jarl, Gustav
Publicado: (2019)

Greater political commitment needed to eliminate malaria
por: Ren, Minghui
Publicado: (2019)

Promising Points for Intervention in Re-Imagining Partnered Research in Health Services Comment on "Experience of Health Leadership in Partnering with University-Based Researchers in Canada – A Call to ‘Re-imagine’ Research"
por: Canas, Eugenia, et al.
Publicado: (2020)

Can We Re-Imagine Research So It Is Timely, Relevant and Responsive? Comment on "Experience of Health Leadership in Partnering with University-Based Researchers in Canada: A Call to ‘Re-Imagine’ Research"
por: Vindrola-Padros, Cecilia
Publicado: (2020)

The Journal Quartile Details as Indicators for the Quality of Dermatological Research in India from 2012 to 2021
por: Hassan, Waseem
Publicado: (2022)

Would program performance indicators and a nationally coordinated response accelerate the elimination of tuberculosis in Canada?
por: Heffernan, Courtney, et al.
Publicado: (2018)

The 2017 Oslo conference report on neglected tropical diseases and emerging/re-emerging infectious diseases – focus on populations underserved
por: Klohe, Katharina, et al.
Publicado: (2019)

Commitment to gender equality through gender sensitive financing
por: Binagwaho, Agnes, et al.
Publicado: (2021)

Comparison of Crude Population-Level Indicators of Opioid Use and Related Harm in New Zealand and Ontario (Canada)
por: Fischer, Benedikt, et al.
Publicado: (2020)

The cost burden of trastuzumab and bevacizumab therapy for solid tumours in Canada
por: Drucker, A., et al.
Publicado: (2008)

Highlights in soft tissue sarcomas and gastrointestinal stromal tumours (GIST) trials reported at ASCO 2017 Annual Meeting
por: Frezza, Anna Maria, et al.
Publicado: (2017)

When Coproduction Is Unproductive: Comment on "Experience of Health Leadership in Partnering with University-Based Researchers in Canada: A Call to ‘Re-Imagine’ Research"
por: Kreindler, Sara A.
Publicado: (2019)

Stress and sex in malaria parasites: Why does commitment vary?
por: Carter, Lucy M., et al.
Publicado: (2013)

DNA replication licensing in stem cells: Gatekeeping the commitment to proliferation
por: Coller, Hilary A.
Publicado: (2018)

The urgent need for a global commitment to protect healthcare workers
por: Talisuna, Ambrose, et al.
Publicado: (2020)

Daring to share requires intentional and collective commitment to civil discourse
por: Beets, Michael W., et al.
Publicado: (2020)

A Framework for Commitment to Social Justice and Antiracism in Academic Medicine
por: Chesley, Christopher, et al.
Publicado: (2021)

Re: Making Health and Care Systems Fit for and Ageing Population. Why We Wrote It, Who We Wrote It For, and How Relevant It Might Be to Canada
por: Oliver, David
Publicado: (2014)

Reimagining Researchers in Health Research Comment on "Experience of Health Leadership in Partnering With University-Based Researchers in Canada: A Call to ‘Re-Imagine’ Research"
por: Plamondon, Katrina M.
Publicado: (2020)

The Incidence and Prevalence of Primary Central Nervous System (CNS) Tumours in Canada (2010–2017), and the Survival of Patients Diagnosed with CNS Tumours (2008–2017)
por: Walker, Emily V., et al.
Publicado: (2023)

Is Gaining Affective Commitment the Missing Strategy for Successful Change Management in Healthcare?
por: Harrison, Reema, et al.
Publicado: (2022)

Stereotactic Ablative Radio Therapy (SABR) followed by immunotherapy a challenge for individualized treatment of metastatic solid tumours
por: Masucci, Giuseppe V, et al.
Publicado: (2012)

Advancing Health Services Collaborative and Partnership Research Comment on "Experience of Health Leadership in Partnering with University-Based Researchers in Canada – A Call to ‘Re-imagine’ Research"
por: Nyström, Monica E., et al.
Publicado: (2020)

Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada"
por: Gagnon, Marc-André
Publicado: (2020)

Inducible transgenics. New lessons on events governing the induction and commitment in mammary tumorigenesis
por: Hulit, James, et al.
Publicado: (2001)

Are Men More Likely than Women To Commit Scientific Misconduct? Maybe, Maybe Not
por: Kaatz, Anna, et al.
Publicado: (2013)

Global commitments and China’s endeavors to promote health and achieve sustainable development goals
por: Tan, Xiaodong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c2o8anjmk9r8cb26del5vl1etn